Skip to main content

Spoor Johan M.'s Form 4 filing

Perspective Therapeutics, Inc. (CATX) · filed Nov 26, 2024

Accession no.
0000950170-24-130754
Filed
Nov 26, 2024
Trade date
Nov 25, 2024
Filing delay
1 day
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions. Open-market purchases total $100.4K. It was filed 1 day after the trade.

This filing was later replaced by the amendment 0000950170-24-133347 (Dec 4, 2024). Trade tables on this site use the amended version.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Spoor Johan M.CIK 0001535289Director, Officer (CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 25, 2024Common StockPPurchaseAcquired+14,500$3.78F1+$54,810152,072Direct
Nov 25, 2024Common StockPPurchaseAcquired+5,400$3.80+$20,5205,400Indirect
Nov 25, 2024Common StockPPurchaseAcquired+6,600$3.80+$25,08066,600Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.645 to $3.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price in the transactions described in this footnote.

Referenced by the price of 1 transaction in Table I.

Remarks

Exhibit 24 - Power of Attorney

Read the full filing on SEC EDGAR (opens in a new tab)